“Shoemaker’s son always goes barefoot” Anyone reading the news about Life Science companies would believe that everything is OK for them, with billions of dollars in revenue and cash on hand. The reality is that industry fundamentals are shifting, and their future may look different than it does today. While the life sciences business has steadily integrated technologies over the years, the pandemic has increased the innovation demand to unprecedented levels. Top-tier pharmaceutical companies have expedited collaborations and acquisitions, although they could not avoid new brave entrants rattling the industry ranking: A first for a sector shielded from outside investment…...
Is Life Science industry healthy?
3 min read